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Abstract
This case report describes an HIV-positive patient with recurrent tuberculosis in Uganda. After several failed courses
of treatment, the patient was diagnosed with multi-drug resistant tuberculosis (MDR-TB). As adequate in-patient
facilities were unavailable, we advised the patient to remain at home, and he received treatment at home via his
family and a community nurse. The patient had a successful clearance of tuberculosis. This strategy of home-based
care represents an important opportunity for treatment of patients in East Africa, where human resource
constraints and inadequate hospital facilities exist for complex patients at high risk of infection to others.
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Background
Successful treatment of multi-drug resistant tuberculosis
(MDR-TB) in HIV-positive patients is a challenge in
resource-limited settings. In Uganda, the exact magni-
tude of MDR-TB is not known, though a national drug
resistance survey is ongoing. To date, there has not
been any reported successful treatment of MDR-TB
using the home-based approach in East Africa. However,
a recent study conducted in South Africa found that a
similar approach has been effective [1]. In a first
attempt, Mildmay Uganda has successfully treated a
patient with MDR-TB using a home-based approach.
Case presentation
A 42-year old HIV-positive male, in a discordant rela-
tionship, presented to the Mildmay Uganda clinic with a
long-standing cough, chest and abdominal pain, night
sweats, and impairment of short-term memory. The
patient had two previous episodes of pulmonary tuber-
culosis (TB), and on both occasions, this condition was
managed in hospital, and he completed treatment in
accordance with the Uganda Ministry of Health TB pro-
gram standard regimes (2RHZE/6EH and 2RHZES/
1RHZE/5RHE) [2]. On examination in March 2007, the
patient had consolidation of the upper lobe of the left
lung. Investigations showed the sputum ZN smear posi-
tive for AFBs (3+). A diagnosis of TB was made, and
the patient started TB treatment (2RHEZS/1REHZ/
5REH), as per standard guidelines [2]. A sputum sample
was sent to the Ugandan National TB laboratory for
mycobacterium culture; results indicated innumerable
mycobacterium colonies, but unfortunately the labora-
tory could not perform drug sensitivity tests at that
time. Follow-up ZN sputum smears performed 3
months after the patient started treatment were still
positive for AFBs.
After 8 months on treatment, the patient’s sputum
was still positive for AFB. In April 2008, sputum cul-
tures were sent to the mycobacteriology laboratory at
the Joint Clinical Research Centre in Kampala, and
results indicated mycobacterium TB resistant to the fol-
lowing TB drugs: streptomycin, isoniazid, and rifampi-
cin. Colonies showed drug sensitivity to capreomycin,
kanamycin, p-amino salicyclic acid (PAS), and ethiona-
mide. Household members were screened for MDR-TB
and none were found to have TB. Notification was
made to the District Health Office and the National TB
programme at the Ministry of Health, but both were
unable to offer MDR-TB treatment; however, in colla-
boration with Médecins Sans Frontières, capreomycin,
levofloxacin, cycloserine, prothionamide, and PAS, were
made available, and the patient started treatment in* Correspondence: emmanuel.luyirika@mildmay.or.ug
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March 2009. The patient received adherence counseling
for MDR-TB, and his wife agreed to serve as a treat-
ment supporter, which included picking up his medica-
tions from the clinic, ensuring directly observed therapy
at home, and providing feedback about his condition to
the clinic. During the initial treatment phase, a commu-
nity volunteer nurse gave injections to the patient daily
at his home. The patient was advised to stay at home.
Several infection control measures were put in place
after confirmation of MDR-TB. The patient was given
house quarantine, and his wife had a separate bedroom
in the home until he received sputum conversion. The
family was informed about TB transmission, and were
encouraged to open windows and doors during the day.
The patient was counseled on coughing etiquette, and
visitors were restricted from accessing the patient’s
residence.
By July 2009, the sputum ZN smear was found to be
negative, and the patient continued the initial treatments
for another 4 months. By November 2009, the sputum
ZN smear remained negative, and the patient continued
on levofloxacin, cycloserine, prothionamide, and PAS for
12 more months. After achieving sputum conversion
and starting on the continuation phase, the patient
began attending the clinic again for his HIV care; antire-
troviral therapy was continued for the duration of his
MDR-TB treatment as per the Uganda National HIV/
AIDS treatment guidelines and the World Health Orga-
nization [3,4]. Treatment for MDR-TB was completed
in November 2010. The patient has been clinically stable
since this time. He attained a peak CD4 cell count of
214 cells/mm [3] shortly before completing MDR-TB.
He has continually had an undetectable HIV viral load.
His T3, T4, and TSH are in normal ranges. Final spu-
tum tests done in November 2011 at the National TB
programme reference laboratory were negative, both for
mycobacterium culture and sputum smear microscopy.
Conclusions
This case report from Mildmay Uganda demonstrates
successful treatment of MDR-TB using a home-based
approach in Uganda. To our knowledge, this is the first
reported home-based care of MDR-TB from East Africa.
In many settings in Sub-Saharan Africa, MDR-TB is
increasing in prevalence. However, as demonstrated
with our case-report, the infrastructure to accurately
diagnose MDR-TB is frequently lacking and the real
extent of MDR-TB in East Africa at least, is unknown.
Our approach to applying home-based care strategies
comes out of necessity rather than desirability. However,
this may be an example where we have learned impor-
tant lessons from our circumstances. Home-based care
offers several important advantages over facility-based
care, especially for HIV-positive patients who may be
surrounded by other at-risk patients. First, by remaining
at home they decrease their likelihood of infecting other
HIV-positive patients. Second, by remaining at home
they are surrounded by their families and social support
networks. Evidence from South Africa indicates that
mandating patients to remain away from their families
can have devastating consequences and patients are
unlikely to comply with this advice [5]. Third, by enga-
ging family members as supportive individuals in their
family’s medical care, it is an opportunity to both edu-
cate the family and ensure retention and adherence to
therapy. Evidence from an HIV program in Mozambi-
que illustrates excellent outcomes using such an
approach, with low mortality, low loss to follow-up and
excellent adherence [6,7]. Finally, by being cared for at
home, they reduce a burden on the hospital system and
human resource challenges. This is an important burden
in settings such as East Africa. We also recognize that
there are limitations to a home-based care approach,
such as the reliance on family and community, who may
not always be available. We also recognize that since
this is a case report, we are unable to directly compare
the outcomes of the patient to another treated in-
hospital.
The treatment of MDR-TB among HIV-positive
patients in East Africa appears to be possible by employ-
ing a home-based care approach. Task-shifting hospital
strategies into the community may be a long-term solu-
tion to current constraints in terms of hospital infra-
structure and home resources.
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